Red blood cell proteomics;Protéomique du globule rouge

Transfusion Clinique et Biologique

Volumn 17, Issue 3, 2010, Pages 151-164

  Pasini, E M ^a   Mann, M ^b   Thomas, A W ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Comparative proteomics; Proteomics; Red blood cell; Transfusion medicine

Indexed keywords

ALPHA TUBULIN; ANKYRIN; CARBON DIOXIDE; CARRIER PROTEIN; CATALASE; CHAPERONIN; CYTOSKELETON PROTEIN; ERYTHROCYTE BAND 4.1 PROTEIN; ERYTHROCYTE BAND 4.9 PROTEIN; ERYTHROCYTE ENZYME; FLOTILLIN 1; HEAT SHOCK PROTEIN; MEMBRANE PROTEIN; OXYGEN; PEROXIREDOXIN 1; PEROXIREDOXIN 3; PROTEASOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RAB PROTEIN; STOMATIN; TROPOMYOSIN;

ANEMIA; BIOCHEMISTRY; BLOOD TRANSFUSION; CARBON DIOXIDE TRANSPORT; ELECTROSPRAY MASS SPECTROMETRY; ERYTHROCYTE; ERYTHROCYTE SHAPE; ERYTHROCYTE STRUCTURE; GAS EXCHANGE; GLYCOBIOLOGY; HUMAN; LIPIDOMICS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDLINE; METHODOLOGY; MOLECULAR BIOLOGY; NONHUMAN; OXYGEN TRANSPORT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN PROCESSING; PROTEOMICS; SHORT SURVEY;

EID: 77955852283     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2010.05.010     Document Type: Short Survey

References (92)

1. Wintrobe M.M. Blood, pure and eloquent 1980, McGraw-Hill, New York.
2. Wintrobe M.M. Hematology, the blossoming of a science: a story of inspiration and effort 1985, Lea and Febiger, Philadelphia.
3. Learoyd P. A short history of blood transfusion 2006, UK National Blood Service publication, Leeds.
4. Jansky J. Haematologick studie u. psychotiku. Sborn. Klinick 1907, 8:85-139.
5. Landsteiner K. Zur Kenntnis der antifermentative, lytische und agglutinierenden Wirkungen des Blutzerums under der Lymphe. Zentralblatt Bakteriologie 1900, 27:357-362.
6. Perutz M.F. Structure of hemoglobin. Brookhaven Symp Biol 1960, 13:165-183.
7. Kean L.S., Brown L.E., Nichols J.W., Mohandas N., Archer D.R., Hsu L.L. Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure. Exp Hematol 2002, 30:394-402.
8. Wandersee N.J., Birkenmeier C.S., Gifford E.J., Mohandas N., Barker J.E. Murine recessive hereditary spherocytosis, sph/sph, is caused by a mutation in the erythroid alpha-spectrin gene. Hematol J 2000, 1:235-242.
9. De Jong K., Emerson R.K., Butler J., Bastacky J., Mohandas N., Kuypers F.A. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia. Blood 2001, 98:1577-1584.
10. Sorensen S., Rubin E., Polster H., Mohandas N., Schrier S. The role of membrane skeletal-associated alpha-globin in the pathophysiology of beta-thalassemia. Blood 1990, 75:1333-1336.
11. Russel E.S., Fondal E.L. Quantitative analysis of the normal and four alternative degrees of an inherited macrocytic anemia in the house mouse. I. Number and size of erythrocytes. Blood 1951, 6:892-905.
12. Marks P.A., Kovach J.S. Development of mammalian erythroid cells. Curr Top Dev Biol 1966, 1:213-252.
13. Dunn C.D. The differentiation of haemopoietic stem cells. Ser Haematol 1971, 4:1-71.
14. Whitsett C.F. The role of hematopoietic growth factors in transfusion medicine. Hematol Oncol Clin North Am. 1985, 9:23-26.
15. Marks P.A., Rifkind R.A., Bank A. Control of gene expression during erythroid cell differentiation. Adv Exp Med Biol 1974, 44:221-224.
16. Pasini EM, Kirkegaard M, Mortensen P, Mann M and Thomas AW. Deep-coverage rhesus red blood cell proteome: first comparison with the human and mouse red blood cell Blood Transfus 2010;8(Suppl 3):s126-39.
17. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
18. Wiśniewski J.R., Zougman A., Nagaraj N., Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009, 6:359-362.
19. Ringrose J.H., van Solinge W.W., Mohammed S., O'Flaherty M.C., van Wijk R., Heck A.J., et al. Highly efficient depletion strategy for the two most abundant erythrocyte soluble proteins improves proteome coverage dramatically. J Proteome Res 2008, 7:3060-3063.
20. Roux-Dalvai F., Gonzalez de Peredo A., Simó C., Guerrier L., Bouyssié D., Zanella A., et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics 2008, 7:2254-2269.
21. Olivieri E., Herbert B., Righetti P.G. The effect of protease inhibitors on the two-dimensional electrophoresis pattern of red blood cell membranes. Electrophoresis 2001, 22:560-565.
22. Bachi A., Sim C., Restuccia U., Guerrier L., Fortis F., Boschetti E. Performance of combinatorial peptide libraries in capturing the low-abundance proteome of red blood cells. 2. Behavior of resins containing individual amino acids. Anal Chem 2008, 80:3557-3565.
23. Simo C., Bachi A., Cattaneo A., Guerrier L., Fortis F., Boschetti E. Performance of combinatorial peptide libraries in capturing the low-abundance proteome of red blood cells. 1. Behavior of mono- to hexapeptides. Anal Chem 2008, 80:3547-3556.
24. Prenni J.E., Avery A.C., Olver C.S. Proteomics: a review and an example using the reticulocyte membrane proteome. Vet Clin Pathol 2007, 36:13-24.
25. Pasini E.M., Kirkegaard M., Mortensen P., Lutz H.U., Thomas A.W., Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006, 108:791-801.
26. Pantaleo A., De Franceschi L., Ferru E., Vono R., Turrini F. Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells. J Proteomics. 2010, 73(3):445-455.
27. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008, 26:1367-1372.
28. Yawata Y. Cell Membrane: The Red Blooc Cell as a Model 2003, Wiley-VCH, Weinheim.
29. Cohen C.M. The molecular organization of the red cell membrane skeleton. Semin Hematol 1983, 20:141-158.
30. Liu S.C., Derick L.H. Molecular anatomy of the red blood cell membrane skeleton: structure-function relationships. Semin Hematol 1992, 29:231-243.
31. Shen B.V. Red blood cell membranes: structure. Function. Clinical implications 1989, 261-297. Dekker, New York. P. Agre, J.C. Parker (Eds.).
32. Weinstein R.S. Red cell membrane: structure and function 1969, 36-76. Lippincott, Philadelphia. G.A. Jamieson, T.J. Greewalt (Eds.).
33. Katz R., Hamilton J.A., Pownall H.J., Deckelbaum R.J. Brain uptake and utilization of fatty acids, lipids & lipoproteins: recommendations for future research. J Mol Neurosci 2007, 33:146-150.
34. Golan D.E. Red blood cell membrane: structure. Function. Clinical implications 1989, 367-400. Dekker, New York. P. Agre, J.C. Parker (Eds.).
35. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998, 14:111-136.
36. Salzer U., Prohaska R. Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood 2001, 97:1141-1143.
37. Cooper R.A. The red cell membrane 1970, 48-74. Grune and Stratton, New York. R.I. Weed, E.R. Jaffe, P.A. Miescher (Eds.).
38. Cooper R.A. Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N Engl J Med 1977, 297:371-377.
39. Van Deenen L.L.M., de Gier J. The red blood cell 1974, 147-211. Academic Press, New York. D.M. Surgenor (Ed.).
40. Hunt A.N., Alb J.G., Koster G., Postle A.D., Bankaitis V.A. Use of mass spectrometry-based lipidomics to probe PITPalpha (phosphatidylinositol transfer protein alpha) function inside the nuclei of PITPalpha+/+ and PITPalpha-/- cells. Biochem Soc Trans 2004, 32:1063-1065.
41. Hunt A.N., Fenn H.C., Clark G.T., Wright M.M. Lipidomic analysis of the molecular specificity of a cholinephosphotransferase in situ. Biochem Soc Trans 2004, 32:1060-1062.
42. Cheng H., Jiang X., Han X. Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: a shotgun lipidomics study. J Neurochem 2007, 101:57-76.
43. Sysi-Aho M., Vehtari A., Velagapudi V.R., Westerbacka J. Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles. Bioinformatics 2007, 23:i519-528.
44. Nilsson J., Rüetschi U., Halim A., Hesse C., Carlsohn E., Brinkmalm G., et al. Enrichment of glycopeptides for glycan structure and attachment site identification. Nat Methods. 2009, 6(11):809-811.
45. Hizukuri Y., Yamanishi Y., Nakamura O., Yagi F., Goto S., Kanehisa M. Extraction of leukemia specific glycan motifs in humans by computational glycomics. Carbohydr Res 2005, 340:2270-2278.
46. Prabakaran S., Wengenroth M., Lockstone H.E., Lilley K., Leweke F.M., Bahn S. 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia. J Proteome Res 2007, 6:141-149.
47. Low T.Y., Seow T.K., Chung M.C. Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002, 2:1229-1239.
48. Kakhniashvili D.G., Bulla L.A., Goodman S.R. The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol Cell Proteomics 2004, 3:501-509.
49. Tyan Y.C., Jong S.B., Liao J.D., Liao P.C., Yang M.H., Liu C.Y., et al. Proteomic profiling of erythrocyte proteins by proteolytic digestion chip and identification using two-dimensional electrospray ionization tandem mass spectrometry. J Proteome Res 2005, 4:748-757.
50. Thadikkaran L., Siegenthaler M.A., Crettaz D., Queloz P.A., Schneider P., Tissot J.D. Recent advances in blood-related proteomics. Proteomics 2005, 5:3019-3034.
51. Goodman S.R., Kurdia A., Ammann L., Kakhniashvili D., Daescu O. The human red blood cell proteome and interactome. Exp Biol Med (Maywood) 2007, 232:1391-1408.
52. D'Alessandro A., Righetti P.G., Zolla L. The red blood cell proteome and interactome: an update. J Proteome Res. 2010, 9(1):144-163.
53. Kooyman D.L., Byrne G.W., McClellan S., Nielsen D., Tone M., Waldmann H., et al. In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 1995, 269:89-92.
54. Jelezarova E., Luginbuehl A., Lutz H.U. C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation. J Biol Chem 2003, 278:51806-51812.
55. Bykowska K., Duk M., Kusnierz-Alejska G., Kopec M., Lisowska E. Degradation of human erythrocyte surface components by human neutrophil elastase and cathepsin G: preferential digestion of glycophorins. Br J Haematol 1993, 84(4):736-742.
56. Fritz I.B., Burdzy K. Novel action of carnitine: inhibition of aggregation of dispersed cells elicited by clusterin in vitro. J Cell Physiol 1989, 140(1):18-28.
57. Feizi T., Solomon J.C., Yuen C.T., Jeng K.C., Frigeri L.G., Hsu D.K., et al. The adhesive specificity of the soluble human lectin, IgE-binding protein, toward lipid-linked oligosaccharides. Presence of the blood group A, B, B-like, and H monosaccharides confers a binding activity to tetrasaccharide (lacto-N-tetraose and lacto-N-neotetraose) backbones. Biochemistry 1994, 33(20):6342-6349.
58. Timoshenko A.V., Gorudko I.V., Maslakova O.V., Andre S., Kuwabara I., Liu F.T., et al. Analysis of selected blood and immune cell responses to carbohydrate-dependent surface binding of proto- and chimera-type galectins. Mol Cell Biochem 2003, 250(1-2):139-149.
59. Maneva A., Taleva B., Maneva L. Lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes. Z Naturforsch [C] 2003, 58:256-262.
60. Beppu M., Mizukami A., Ando K., Kikugawa K. Antigenic determinants of senescent antigen of human erythrocytes are located in sialylated carbohydrate chains of band-3 glycoprotein. J Biol Chem 1992, 267:14691-14696.
61. Lutz H.U., Bussolino F., Flepp R., Fasler S., Stammler P., Kazatchkine M.D., et al. Naturally occurring anti-band 3 antibodies and complement together mediate phagocytosis of oxidatively stressed human red blood cells. Proc Natl Acad Sci U S A 1987, 84:7368-7372.
62. Lutz H.U., Gianora O., Nater M., Schweizer E., Stammler P. Naturally occurring anti-band 3 antibodies bind to protein rather than to carbohydrate on band 3. J Biol Chem 1993, 268:23562-23566.
63. Bellussi G., Muccioli G., Ghe C., Di Carlo R. Prolactin binding sites in human erythrocytes and lymphocytes. Life Sci 1987, 41(8):951-959.
64. Mohandas N., Chasis J.A. Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol 1993, 30:171-192.
65. Pasini E.M., Lutz H.U., Mann M., Thomas A.W. Red blood cell (RBC) membrane proteomics-Part I: Proteomics and RBC physiology. J Proteomics 2010, 73:403-420.
66. Pasini E.M., Lutz H.U., Mann M., Thomas A.W. Red blood cell (RBC) membrane proteomics-Part II: Comparative proteomics and RBC patho-physiology. J Proteomics 2010, 73(3):421-435.
67. Zolla L. Proteomics and transfusion medicine. Blood Transfus 2008, 6:67-69.
68. D'Amici G.M., Rinalducci S., Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage. J Proteome Res 2007, 6:3242-3255.
69. Anniss A.M., Glenister K.M., Killian J.J., Sparrow R.L. Proteomic analysis of supernatants of stored red blood cell products. Transfusion 2005, 45:1426-1433.
70. Queloz P.A., Thadikkaran L., Crettaz D., Rossier J.S. Proteomics and transfusion medicine: future perspectives. Proteomics 2006, 6:5605-5614.
71. Bosman G.J., Lasonder E., Luten M., Roerdinkholder-Stoelwinder B., Novotny V.M., Bos H., et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008, 48:827-835.
72. Sparrow R.L., Healey G., Patton K.A., Veale M.F. Red blood cell age determines the impact of storage and leukocyte burden on cell adhesion molecules, glycophorin A and the release of annexin V. Transfus Apher Sci 2006, 34:15-23.
73. Liumbruno G., D'Amici G.M., Grazzini G., Zolla L. Transfusion medicine in the era of proteomics. J Proteomics 2008, 71:34-45.
74. Goardon N., Lambert J.A., Rodriguez P., Nissaire P. ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. Embo J 2006, 25:357-366.
75. Unwin R.D., Smith D.L., Blinco D., Wilson C.L. Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. Blood 2006, 107:4687-4694.
76. Brand M., Ranish J.A., Kummer N.T., Hamilton J. Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics. Nat Struct Mol Biol 2004, 11:73-80.
77. Claverol S., Burlet-Schiltz O., Girbal-Neuhauser E., Gairin J.E., Monsarrat B. Mapping and structural dissection of human 20 S proteasome using proteomic approaches. Mol Cell Proteomics 2002, 1:567-578.
78. Froment C., Uttenweiler-Joseph S., Bousquet-Dubouch M.P., Matondo M. A quantitative proteomic approach using two-dimensional gel electrophoresis and isotope-coded affinity tag labeling for studying human 20S proteasome heterogeneity. Proteomics 2005, 5:2351-2363.
79. Wilkinson D.K., Turner E.J., Parkin E.T., Garner A.E. Membrane raft actin deficiency and altered Ca(2+)-induced vesiculation in stomatin-deficient overhydrated hereditary stomatocytosis. Biochim Biophys Acta 2008, 1778:125-132.
80. Denecke J., Kranz C., Nimtz M., Conradt H.S. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS). Glycoconj J 2008, 25:375-382.
81. De Franceschi L., Biondani A., Carta F., Turrini F., Laudanna C., Deana R., et al. PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. Proteomics 2008, 8:4695-4708.
82. Friedman J.S., Lopez M.F., Fleming M.D., Rivera A. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood 2004, 104:2565-2573.
83. Lutz H.U. Innate immune and non-immune mediators of erythrocyte clearance. Cell Mol Biol (Noisy-le-grand) 2004, 50:107-116.
84. Kakhniashvili D.G., Griko N.B., Bulla L.A., Goodman S.R. The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. Exp Biol Med (Maywood) 2005, 230:787-792.
85. Haynes J., Obiako B., King J.A., Hester R.B., Ofori-Acquah S. Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. Am J Physiol Heart Circ Physiol 2006, 291:H1679-1685.
86. Haynes J., Obiako B., Hester R.B., Baliga B.S., Stevens T. Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium. Am J Physiol Heart Circ Physiol 2008, 294:H379-385.
87. Ghatpande S.S., Choudhary P.K., Quinn C.T., Goodman S.R. Pharmaco-proteomic study of hydroxyurea-induced modifications in the sickle red blood cell membrane proteome. Exp Biol Med (Maywood) 2008, 233:1510-1517.
88. Yoo K.Y., Shin H.R., Chang S.H., Choi B.Y., Hong Y.C., Kim D.H., et al. Genomic epidemiology cohorts in Korea: present and the future. Asian Pac J Cancer Prev 2005, 6:238-243.
89. Jiang M., Jia L., Jiang W., Hu X. Protein disregulation in red blood cell membranes of type 2 diabetic patients. Biochem Biophys Res Commun 2003, 309:196-200.
90. Bryant N.J., Govers R., James D.E. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 2002, 3:267-277.
91. Jiang M., Ding Y., Su Y., Hu X. Arginase-flotillin interaction brings arginase to red blood cell membrane. FEBS Lett 2006, 580:6561-6564.
92. Pasini E.M., Kirkegaard M., Salerno D., Mortensen P., Mann M., Thomas A.W. Deep-coverage mouse red blood cell proteome: a first comparison with the human red blood cell. Mol Cell Proteomics 2008, 7:1317-1330.